Is cannabis use associated with less opioid use among people who inject drugs?

Drug and Alcohol Dependence

Volumn 153, Issue , 2015, Pages 236-241

  Kral, Alex H ^a   Wenger, Lynn ^a   Novak, Scott P ^a   Chu, Daniel ^c   Corsi, Karen F ^b   Coffa, Diana ^d   Shapiro, Brad ^d,e   Bluthenthal, Ricky N ^c  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabis; Epidemiology; Injection drug use; Opioids; PWID

Indexed keywords

CANNABIS; DIAMORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CANNABIS USE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISCELLANEOUS NAMED GROUPS; OPIATE ADDICTION; PAIN; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; ADOLESCENT; CALIFORNIA; CANNABIS SMOKING; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDY; SUBSTANCE ABUSE; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LOS ANGELES; MALE; MARIJUANA SMOKING; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84937631174     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.05.014     Document Type: Article

References (30)

1. Abrams D.I., Couey P., Shade S.B., Kelly M.E., Benowitz N.L. Cannabinoid-opioid interaction in chronic pain. Clin. Pharmacol. Ther. 2011, 90:844-851.
2. Baker D., Pryce G., Giovannoni G., Thompson A.J. The therapeutic potential of cannabis. Lancet Neurol. 2003, 2:291-298.
3. Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J. Ethnopharmacol. 2006, 105:1-25.
4. Bluthenthal R.N., Watters J.K. Multimethod research from targeted sampling to HIV risk environments. NIDA Res. Monogr. 1995, 157:212-230.
5. Bostwick J.M. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin. Proc. 2012, 87:172-186.
6. Bostwick J.M. The use of cannabis for management of chronic pain. Gen. Hosp. Psychiatry 2014, 36:2-3.
7. Cagle H.H., Fisher D.G., Senter T.P., Thurmond R.D., Kaster A.J. Classifying Skin Lesions of Injection Drug Users: A Method for Corroborating Disease Risk 2002, Substance Abuse and Mental Health Services Administration, Treatment CfSA, Rockville, MD, (Substance Abuse and Mental Health Services Administration, Treatment CfSA (ed.)).
8. Carter G.T., Javaher S.P., Nguyen M.H., Garret S., Carlini B.H. Re-branding cannabis: the next generation of chronic pain medicine?. Pain Manage. 2015, 5:13-21.
9. Centers for Disease Control and Prevention Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR 2011, 60:1487-1492.
10. Cohen P.J. Medical marijuana 2010: it's time to fix the regulatory vacuum. J. Law Med. Ethics 2010, 38:654-666.
11. Degenhardt L., Lintzeris N., Campbell G., Bruno R., Cohen M., Farrell M., Hall W.D. Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Drug Alcohol Depend. 2014, 147:144-150.
12. Elikkottil J., Gupta P., Gupta K. The analgesic potential of cannabinoids. J. Opioid Manage. 2009, 5:341-357.
13. Grotenhermen F., Muller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch. Arztebl. Int. 2012, 109:495-501.
14. Kalant H. Cannabis in the treatment of rheumatic diseases: suggestions for a reasoned approach. J. Rheum. 2014, 42:146-148.
15. Kral A.H., Malekinejad M., Vaudrey J., Martinez A.N., Lorvick J., McFarland W., Raymond H.F. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J. Urban Health 2010, 87:839-850.
16. Kumar R.N., Chambers W.A., Pertwee R.G. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001, 56:1059-1068.
17. Lee M., Silverman S.M., Hansen H., Patel V.B., Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011, 14:145-161.
18. Li H.L. An archaelogical and historical account of cannabis in China. Econ. Bot. 1974, 28:437-448.
19. Lucas P. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. J. Psychoact. Drugs 2012, 44:125-133.
20. Merica D. Oregon, Alaska and Washington, DC Legalize Marijuana 2014, CNN.
21. O'Connell T.J., Bou-Matar C.B. Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm. Reduct. J. 2007, 4:16.
22. Peters D.C. Patients and caregivers report using medical marijuana to decrease prescription narcotics use. Humboldt J. Soc. Relat. 2013, 35:24-40.
23. Portal Labs Medical Marijuana Laws for Patients 2014, vol. 2015. Public Health Law Research.
24. Raby W.N., Carpenter K.M., Rothenberg J., Brooks A.C., Jiang H., Sullivan M., Bisaga A., Comer S., Nunes E.V. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am. J. Addict. 2009, 18:301-308.
25. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br. J. Psychiatry 2001, 178:107-115.
26. Svendsen K., Borchgrevink P., Fredheim O., Hamunen K., Mellbye A., Dale O. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat. Med. 2011, 25:725-732.
27. Walsh Z., Callaway R., Belle-Isle L., Capler R., Kay R., Lucas P., Holtzman S. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int. J. Drug Policy 2013, 24:511-516.
28. Watters J.K., Biernacki P. Targeted sampling: options for the study of hidden populations. Soc. Probl. 1989, 36:416-430.
29. Wenger L.D., Lopez A.M., Comfort M., Kral A.H. The phenomenon of low-frequency heroin injection among street-based urban poor: drug user strategies and contexts of use. Int. J. Drug Policy 2014, 25:471-479.
30. Woolridge E., Barton S., Samuel J., Osorio J., Dougherty A., Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J. Pain Symptom Manage. 2005, 29:358-367.